Nonin Medical Celebrates 40 Years in Business

PLYMOUTH, Minnesota—Nonin Medical, a global manufacturer of wearable and non-invasive patient monitoring solutions, is celebrating its 40th anniversary in 2026, marking four decades of patient monitoring and work with clinicians, sleep specialists, homecare providers, respiratory therapists and original equipment manufacturers (OEM) customers worldwide. 

As part of its anniversary year, the appointment of Todd Austin as CEO positions a clinician-executive to guide the next chapter of growth. A registered respiratory therapist, registered pulmonary function technologist and neonatal-pediatric specialist, Austin began his career at the bedside in the early 1980s, caring for critically ill patients in neonatal and pediatric intensive care. 

Austin witnessed the emergence of pulse oximetry as the “fifth vital sign,” a transformation that changed how clinicians assess and manage respiratory conditions. Over a career spanning SensorMedics, VIASYS Healthcare, CareFusion and, most recently, as president and CEO of MGC Diagnostics, Austin has translated clinical insight into commercial leadership across pulmonary diagnostics, sleep medicine and global medical technology.

“From the very beginning, our goal was to give clinicians data they could depend on without question,” said Phil Isaacson, founder and executive chairman of the board for Nonin Medical. “Trust is earned through consistency, evidence and performance. For four decades, every product we have ever built starts and ends with those standards.”

Isaacson will continue to serve as executive chairman and chief technology officer as the company enters its fifth decade.

“Nonin was a familiar part of my clinical work long before I ever imagined leading the company,” said Austin. “As a clinician, you learn very quickly that accuracy is not a feature; it’s a responsibility. Forty years of trust is something you protect fiercely, even as you push forward with the next wave of innovation.”

Austin said his vision for Nonin’s next chapter centers on expanding what the company’s legacy of accuracy can deliver as health care evolves rapidly toward connected, home-based and personalized care models. 

“Our legacy of accuracy is strong,” Austin said. “Our future of innovation is even stronger. What excites me most is the shift toward proactive, connected care that can reach patients wherever they are, and the recognition that its success depends on one fundamental principle: the data must be accurate, reliable and accessible. For forty years, that has been Nonin’s standard. As care becomes more connected and more personal, that foundation becomes even more critical.”